According to Mexican TV network Televisa, the Guanauato state government bought unauthorized Chinese medicines for public distribution through IMSS (Instituto Mexicano del Seguro Social), but not only that, the supplier companies did not meet the minimum requirements, and were still granted direct contracts for almost 4 billion pesos ($200 million USD).
This unusable Chinese insulin, is not only ineffective, but it also puts the state’s population at risk.
The two companies in question are Distribuidora Internacional de Medicamentos y Equipo Médico S.A de C.V, and Intercontinental de Medicamentos S.A de C.V. These companies were initially disqualified as suppliers by Guanauato authorities for not meeting the minimum requirements; but nervertheless, Finance Secretary of Guanajuato, Ignacio Martin Solis, authorized direct contracts for both of them.
The insulin provided by these companies had presented irregularities since 2013, and the government not only did not sanction them, but inexplicably continued conducting business with both of them.
The state government declared that, during the administration of governor Miguel Marquez Marquez, these contracts have been granted directly, allegedly because all companies that entered the bid, did not meet the proper requirements.
Social Security patients in the state of Guanajuato, who are entitled to free of cost medicine, told Televisa network that sometimes the insulin is not available for up to 30 days, which forces them to buy it at drugstores with their own money.
In this regard, Guanajuato Health Secretary Ignacio Ortiz Aldana declared that the state government has never bought Chinese medicines.
“We’ve never bought Chinese insulin,” Ortiz Aldana said in an interview broadcast on Despierta with Televisa’s Carlos Loret de Mola when asked about the distribution of medication that was allegedly not responding in patients with diabetes.
The Health Secretary stated they have patient controls and no consequences have been detected in any of the IMSS hospitals statewide.
He also pointed out that the insulin prescribed complies with the basic framework requirements of the Federal Commission for Protection against Health Risks (Comisión Federal de Protección contra riesgos de salud: Cofepris).
When questioned about the documents where it is said that the medication is not having effect in some patients, he said that this is just an “isolated incident”, without giving more details.
Meanwhile, the undersecretary of Finance, Angel Isidro Macías Barrón, said that purchases of medicines are made with total transparency and recognized that some suppliers were sanctioned but not for this situation, but for the price of the product. He added that Guanajuato holds first place in satisfaction among health users.
more recommended stories
600 new police for Cancun, Playa del Carmen and Tulum Quintana Roo
According to riviera-maya-news.com, approximately 600 new.
Teen jogger who accidentally crossed U.S. border from Canada is detained for two weeks
A teenager out for a beachside.
Grand Finale of the 2018 Merida Initiative National Mock Trial Competition for Mexican Law Students
Mexico City, 21 June, 2018 –.
Three time NBA Champion Klay Thompson charters plane to Mexico full of IG models
Three-time champion Klay Thompson is in.
Mexico’s soccer national team mental coach is transforming mindsets nationwide
Though the spotlight is always on.
Maya sacred book “Chilam Balam Tekax” astrological predictions analyzed by INAH experts
The first specialized integral study of.
Prisma Hotel Group announces investment of 357 million for remodeling hotels nationwide
With the objective of always providing.
Trump’s ‘Tent Cities’: where unaccompanied minors are kept in South Texas
According to Esquire: Beyond the moral and.
“Mayas y Piratas” Festival in Chetumal
The Bay of Chetumal will host.
The current ESAY premises will be turned into the new University of the Arts
“The transformation of the Higher School.